greeksoup/ stock research

Cardinal Health (CAH) Q1 FY2027 earnings: revenue $67.5 billion, up 5.5% on the year

Cardinal Health Inc. (CAH) reported revenue of $67.5 billion for Q1 FY2027, the quarter ended 30 September 2026, up 5.5% on the same quarter a year earlier. Net income was $554 million, up 23.1% on the year, and diluted earnings per share $2.38. The figures are the company's own, from the 10-Q it filed with the SEC on 5 November 2026.

Revenue
$67.5 billion
+5.5% on the year · +6.0% on the quarter
Q2 FY2025Q1 FY2027
Operating margin
1.1%
1.0% a year earlier
Q2 FY2025Q1 FY2027
Net income
$554 million
+23.1% on the year · +39.2% on the quarter
Q2 FY2025Q1 FY2027
Diluted EPS
$2.38
+26.6% on the year · +40.0% on the quarter
Q2 FY2025Q1 FY2027

this quarterthe same quarter a year earlierHover a bar for its figure.

What management said

Guidance figures: 5 raised, 2 lowered.

  • Revenue and operating earnings grew: Revenue rose 5% to $67.5 billion. GAAP operating earnings rose 13% to $753 million, from $668 million a year earlier.
  • Non-GAAP EPS rose 28%: Non-GAAP diluted EPS rose 28% to $3.26. The company attributes the increase to higher non-GAAP operating earnings, a lower share count and a lower effective tax rate.
  • Pharma revenue and profit grew: Pharmaceutical and Specialty Solutions revenue rose 6% to $62.6 billion. Segment profit rose 17% to $783 million, driven by brand and specialty products and generics program performance.
Read the earnings call summary

Income statement (profit and loss)

$ millionQ1 FY2027Q4 FY2026Q1 FY2026On the quarterOn the yearLast 8 quarters
Revenue67,51363,67264,009+6.0%+5.5%
Cost of revenue64,91761,11261,690+6.2%+5.2%
Gross profit2,5962,5602,319+1.4%+11.9%
Gross margin3.8%4.0%3.6%
Selling, general and administrative1,5951,6251,461-1.8%+9.2%
Operating income753729668+3.3%+12.7%
Operating margin1.1%1.1%1.0%
Interest expense73.079.080.0-7.6%-8.8%
Pre-tax income688554598+24.2%+15.1%
Income tax132154144-14.3%-8.3%
Effective tax rate19.2%27.8%24.1%
Net income554398450+39.2%+23.1%
Net margin0.8%0.6%0.7%
Diluted EPS$2.38$1.70$1.88+40.0%+26.6%
$ million except per share.
Read moreFourth quarters are the year less the first three quarters. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionQ1 FY2027Q4 FY2026Q1 FY2026On the quarterOn the yearLast 8 quarters
Operating cash flow1,3981,692973-17.4%+43.7%
Capital expenditure157264108-40.5%+45.4%
Free cash flow1,2411,428865-13.1%+43.5%
Free cash flow margin1.8%2.2%1.4%
Cash from investing-251-281-142
Cash from financing-742-490-110
Depreciation and amortisation247241233+2.5%+6.0%
Share-based compensation10958.093.0+87.9%+17.2%
Buybacks500350375+42.9%+33.3%
Dividends paid126120129+5.0%-2.3%
Dividend per share$0.52n/a$0.51+1.0%
Diluted shares, weighted233m235m239m-0.9%-2.5%
Shares outstanding at period end231m233m238m-0.6%-2.7%

Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.

Balance sheet

$ millionQ1 FY2027Q4 FY2026Q1 FY2026On the quarterOn the yearLast 8 quarters
Shareholders' equity-3,025-2,883-2,879
Non-controlling interest1591591480.0%+7.4%
Debt8,8158,8869,032-0.8%-2.4%
Operating lease liabilitiesn/a861n/a
Finance lease liabilitiesn/a140n/a
Other liabilities53,59550,13648,927+6.9%+9.5%
Total liabilities and equity59,54457,29955,228+3.9%+7.8%
Fixed assets2,9993,0312,831-1.1%+5.9%
Goodwill11,54311,4429,711+0.9%+18.9%
Intangible assets2,1462,1892,399-2.0%-10.5%
Cash and equivalents5,2644,8564,593+8.4%+14.6%
Receivables14,54213,81513,770+5.3%+5.6%
Inventory18,39517,29717,559+6.3%+4.8%
Other assets4,6554,6694,365-0.3%+6.6%
Total assets59,54457,29955,228+3.9%+7.8%

Questions

What was Cardinal Health's revenue in Q1 FY2027?

Cardinal Health (CAH) reported revenue of $67.5 billion for Q1 FY2027, the quarter ended 30 September 2026, up 5.5% on the same quarter a year earlier.

How much did Cardinal Health earn in Q1 FY2027?

Net income for Q1 FY2027 was $554 million, up 23.1% on the year, and diluted earnings per share $2.38.

When did Cardinal Health report Q1 FY2027 results?

Cardinal Health filed its 10-Q for the quarter ended 30 September 2026 with the SEC on 5 November 2026.

Quarterly results, the last 20 quarters

Q2 FY2022Q3 FY2022Q4 FY2022 *Q1 FY2023 †Q2 FY2023 †Q3 FY2023 †Q4 FY2023 * †Q1 FY2024 †Q2 FY2024 †Q3 FY2024 †Q4 FY2024 * †Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025 *Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026 *Q1 FY2027
Revenue45,45744,83647,10349,60351,46950,48753,45354,65057,44554,91159,70852,27755,26454,87860,15964,00965,62760,94063,67267,513
Cost of revenue43,84143,15445,49847,98949,80648,70251,62652,99555,59952,96457,85550,37553,32352,75557,95761,69063,23058,44261,11264,917
Gross profit1,6161,6821,6051,5961,6841,8101,7841,7431,8541,9351,8821,9021,9412,1232,2022,3192,3972,4982,5602,596
Gross margin4%4%3%3%3%4%3%3%3%4%3%4%4%4%4%4%4%4%4%4%
SG&A1,1511,1371,1551,1971,1791,1721,2521,1861,2681,2691,2771,2771,3061,3151,4841,4611,5041,5421,6251,595
Operating income-950-97.036.0123-86.0604111-32.0505369401568549730428668707509729753
Operating margin-2%-0%0%0%-0%1%0%-0%1%1%1%1%1%1%1%1%1%1%1%1%
Interest expense37.038.034.024.024.026.010.011.03.028.09.032.035.074.074.080.088.010179.073.0
Pre-tax income-973-137-28.096.0-10457695.0-44.0512342391541511665384598630392554688
Tax raten/an/an/a-3%n/a36%161%n/a28%23%40%23%22%24%37%24%25%3%28%19%
Net income49.0-1,39113898.0-77.0365-56.0-12.0368261235416400506239450467399398554
Net margin0%-3%0%0%-0%1%-0%-0%1%0%0%1%1%1%0%1%1%1%1%1%
Diluted EPS$0.17-$5.05$0.59$0.40-$0.30$1.41-$0.51-$0.05$1.50$1.07$0.96$1.70$1.65$2.10$1.00$1.88$1.97$1.69$1.70$2.38
Operating cash flow1,195-4192,99223.05971,3618585281,189-49.02,077-1,647-4002,9171,5279736861,8231,6921,398
Capital expenditure74.082.016470.085.010921792.011411219390.099.0126232108131146264157
Free cash flow1,121-5012,828-47.05121,2526414361,075-1611,884-1,737-4992,7911,2958655551,6771,4281,241
Buybacks3002000.01,0002502505005002500.00.037515.03750.0375383250350500
Dividends paid140136134142129128126131124122122128122124120129122120120126
Shares outstanding277m272m273m262m258m255m251m246m243m244m244m242m242m239m239m238m235m234m233m231m
Filing10-Q10-Q10-K10-K10-K10-K10-K10-K10-K10-K10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q
Each quarter as filed, linked to its filing.
Read more* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS, and its diluted share count where shown, are from the company's results press release for that quarter, checked against the company's filed figures or a second data source. A quarter marked † is shown as the company last restated it in a later filing, so it compares with the quarters around it on one basis; rest on a figure for the one first filed. EPS is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

10-Q for the period ended 30 September 2026, filed 5 November 2026: the filing.